MultiStem

 

Topic mentions per year

Topic mentions per year

2008-2016
01220082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
I schemic stroke is caused by a blockage of blood flow to the brain. A leading cause of death and disability globally, each year… (More)
  • table 1
  • table 2
Is this relevant?
2016
2016
: MultiStem cells are clinical-grade multipotent adult bone marrow-derived progenitor cells (MAPCs), with extensive replication… (More)
Is this relevant?
2015
2015
We conducted a multicenter, phase 1 dose escalation study evaluating the safety of the allogeneic multipotent adult progenitor… (More)
Is this relevant?
2014
2014
BACKGROUND There is growing interest in neurorestorative and reparative therapies after acute stroke. MultiStem is an allogeneic… (More)
Is this relevant?
2012
2012
RATIONALE MultiStem is an allogeneic bone marrow-derived adherent adult stem cell product that has shown efficacy in preclinical… (More)
Is this relevant?
2012
2012
Mucopolysaccharidosis type I (MPS-I; Hurler syndrome) is an inborn error of metabolism caused by lack of the functional lysosomal… (More)
Is this relevant?
Review
2012
Review
2012
The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase… (More)
  • table 2
  • figure 1
Is this relevant?
2011
2011
Athersys (Nasdaq: ATHX) is a biopharmaceutical company engaged in the discovery and development of novel therapies designed to… (More)
Is this relevant?
2009
2009
The therapeutic benefits of adult adherent stem cells are currently being investigated in clinical trials for a variety of… (More)
Is this relevant?
2008
2008
BACKGROUND Successful clinical development of novel cellular therapeutics requires the evaluation of clinical acute toxicity… (More)
Is this relevant?